Delivery Order SPE2DX22D0049-SPE2D826FA1BX

AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a Delivery Order valued at $7,930.98 under a Firm Fixed Price contract by the Defense Logistics Agency's Medical Supply Chain on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-set-aside award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 through December 2026. The delivery order calls for pharmaceutical products and medical supplies to support federal medical procurement needs, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.

This award reflects AmerisourceBergen's role as a critical vendor for military and veteran healthcare systems, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's competitively awarded contracts with DLA demonstrate its capability to fulfill federal medical supply requirements across a wide spectrum of pharmaceutical products and medical supplies. The performance location for this delivery order is Conshohocken, Pennsylvania, where the company maintains its corporate office operations. As part of DLA's Pharmaceutical Prime Vendor Global Program planning initiatives, AmerisourceBergen is positioned among multiple potential contractors to support regional pharmaceutical supply needs for the Department of Defense medical infrastructure.